🔗 Permalink

Inventor profile of:

Omar Duramad

City:

Berkeley, California

Country:

United States

Published Applications:

Last publication date:

2026-04-16

Top Assignees for applications by Omar Duramad

The entities that hold a legal rights for patent applications filed by inventor Duramad Omar:

Biograph 55, Inc. 3 San Francisco, CA United States
Abmuno Therapeutics LLC 2 Berkeley, CA United States
JN Biosciences LLC 2 Mountain View, CA United States
REGiMMUNE Corporation 1 Chuo-ku, Japan
REGIMMUNE CORPORATION 1 Chuo-ku, Tokyo, Japan
IGM Biosciences, Inc. 1 Mountain View, CA United States

Recent patent applications by Duramad Omar

Omar Duramad from Berkeley, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-16

US20260103536A1

Chemistry; metallurgy

ANTI-CD19/ANTI-CD38 COMMON LIGHT CHAIN BISPECIFIC ANTIBODIES

#2 | 2025-01-02

US20250000991A1

Human necessities

NECTIN-4 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

#3 | 2024-11-28

US20240392000A1

Chemistry; metallurgy

METHODS OF TREATING CANCERS ASSOCIATED WITH IMMUNOSUPPRESSIVE B CELLS

#4 | 2024-10-24

US20240352156A1

Chemistry; metallurgy

ANTIBODIES TARGETING IMMUNOSUPPRESSIVE B CELLS

#5 | 2024-04-11

US20240115696A1

Human necessities

ANTIBODIES TO TIGIT

#6 | 2022-11-17

US20220363774A2

Chemistry; metallurgy

ANTI-CD19/ANTI-CD38 COMMON LIGHT CHAIN BISPECIFIC ANTIBODIES

#7 | 2022-06-16

US20220185908A1

Chemistry; metallurgy

METHODS OF USE OF ANTI-CD19/ANTI-CD38 COMMON LIGHT CHAIN BISPECIFIC ANTIBODIES

#8 | 2022-06-16

US20220185907A1

Chemistry; metallurgy

ANTI-CD19/ANTI-CD38 COMMON LIGHT CHAIN BISPECIFIC ANTIBODIES

#9 | 2022-06-16

US20220185906A1

Chemistry; metallurgy

ANTI-CD19/ANTI-CD38 COMMON LIGHT CHAIN BISPECIFIC ANTIBODIES

#10 | 2021-09-02

US20210269545A1

Chemistry; metallurgy

Composite binding molecules targeting immunosuppressive B cells

#11 | 2020-09-24

US20200297844A1

Human necessities

Antibodies to TIGIT

#12 | 2019-04-04

US20190100597A1

Chemistry; metallurgy

Multimeric bispecific binding molecules specific for CD20 and CD3

#13 | 2017-10-05

US20170281764A1

Human necessities

Antibodies to TIGIT

#14 | 2015-08-27

US20150238572A1

Human necessities

Preparation for preventing or treating type I diabetes

InventorID:

1267732 ⎘